Creative Planning
MXCT icon

Creative Planning’s MaxCyte MXCT Stock Holding History

Creative Planning’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5K Buy
32,944
+21,973
+200% +$21.9K ﹤0.01% 4139
2026
Q1 		$7.71K Buy
+10,971
New +$10.2K ﹤0.01% 4079
2025
Q1 		– Sell
-348
Closed -$1.45K – 3641
2024
Q4 		$1.45K Sell
348
-28,304
-99% -$107K ﹤0.01% 3494
2024
Q3 		$111K Buy
28,652
+7,212
+34% +$30.4K ﹤0.01% 2996
2024
Q2 		$84K Buy
+21,440
New +$92.2K ﹤0.01% 2874

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Creative Planning's MXCT Position: Q2 2026 in Review

Creative Planning increased its MaxCyte (MXCT) stake by 200% in Q2 2026, buying an estimated $21.9K and bringing the position to 32,944 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4139.

Creative Planning first reported a position in MXCT in Q2 2024 and has held it in 5 quarters since. The position peaked at $111K in Q3 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Creative Planning held 32,944 shares of MaxCyte worth $40.5K as of Q2 2026.
  • Creative Planning bought 21,973 MaxCyte shares in Q2 2026, an estimated $21.9K.
  • MaxCyte made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4139 holding.
  • Creative Planning first reported a position in MaxCyte in Q2 2024 and has held it in 5 quarters since.
  • Creative Planning's MaxCyte position peaked at $111K in Q3 2024.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.